Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
All content for The Latest Dose is the property of Oracle Corporation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
Ep. 40: CancerX: Breaking down the barriers to digital innovation use in oncology
The Latest Dose
30 minutes 52 seconds
2 years ago
Ep. 40: CancerX: Breaking down the barriers to digital innovation use in oncology
The Latest Dose
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
